Genomic Medicine: A Decade of Successes, Challenges, and Opportunities-Reference-Cited by-同舟云学术

Genomic Medicine: A Decade of Successes, Challenges, and Opportunities

Published:2013-06-12 Issue:189 Volume:5 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

McCarthy Jeanette J.¹²,McLeod Howard L.³,Ginsburg Geoffrey S.¹

Affiliation:

1. Institute for Genome Sciences & Policy, Duke University, Durham, NC 27708, USA.

2. Department of Epidemiology and Biostatistics, UCSF School of Medicine, San Francisco, CA 94105, USA.

3. Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill, NC 27599, USA.

Abstract

This State of the Art Review highlights the ways in which genomic tools and information are being used in clinical medicine, the big challenges in their uptake and implementation, and the forces that will shape genomic medicine in the future.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference169 articles.

1. Clinical application of pharmacogenetics

2. Complement Factor H Polymorphism in Age-Related Macular Degeneration

3. K. A. Wetterstrand DNA sequencing costs: Data from the NHGRI Genome Sequencing Program (GSP); http://www.genome.gov/sequencingcosts.

4. Initial impact of the sequencing of the human genome

5. Diagnostic Applications of High-Throughput DNA Sequencing

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of NGS platforms and technological advancements for forensic applications;Next Generation Sequencing (NGS) Technology in DNA Analysis;2024

2. Forensic DNA phenotyping using next-generation sequencing;Next Generation Sequencing (NGS) Technology in DNA Analysis;2024

3. Education of health providers on precision medicine;Comprehensive Precision Medicine;2024

4. Pan-Cancer Drug Response Prediction Using Integrative Principal Component Regression;2023-10-05

5. Psoriasis: Striving for Potential Biomarkers;ASSAY and Drug Development Technologies;2023-09-01